James Vardiman to Humans
This is a "connection" page, showing publications James Vardiman has written about Humans.
Connection Strength
0.607
-
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018 03 21; 9(1):1163.
Score: 0.021
-
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med. 2017 Oct; 141(10):1342-1393.
Score: 0.020
-
Acute Myeloid Leukemia With Myelodysplasia-Related Changes. Am J Clin Pathol. 2015 Jul; 144(1):29-43.
Score: 0.018
-
A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease. Am J Clin Pathol. 2013 May; 139(5):622-32.
Score: 0.015
-
Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome. Leukemia. 2013 Jun; 27(6):1291-300.
Score: 0.015
-
The classification of MDS: from FAB to WHO and beyond. Leuk Res. 2012 Dec; 36(12):1453-8.
Score: 0.014
-
Myelodysplastic/myeloproliferative neoplasms. Semin Diagn Pathol. 2011 Nov; 28(4):283-97.
Score: 0.014
-
Acute myeloid leukemia with expanded erythropoiesis. Haematologica. 2011 Sep; 96(9):1241-3.
Score: 0.013
-
World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants. Hematology Am Soc Hematol Educ Program. 2011; 2011:250-6.
Score: 0.013
-
Myelodysplastic syndromes. N Engl J Med. 2009 Nov 05; 361(19):1872-85.
Score: 0.012
-
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact. 2010 Mar 19; 184(1-2):16-20.
Score: 0.012
-
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009 Nov; 6(11):627-37.
Score: 0.012
-
The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer. 2009 Sep 01; 115(17):3842-7.
Score: 0.012
-
Chronic myelogenous leukemia, BCR-ABL1+. Am J Clin Pathol. 2009 Aug; 132(2):250-60.
Score: 0.012
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51.
Score: 0.011
-
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008 Jan; 22(1):14-22.
Score: 0.010
-
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007 Aug 15; 110(4):1092-7.
Score: 0.010
-
The diagnostic interface between histology and molecular tests in myeloproliferative disorders. Curr Opin Hematol. 2007 Mar; 14(2):115-22.
Score: 0.010
-
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol. 2007 Feb; 127(2):197-205.
Score: 0.010
-
Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl. Best Pract Res Clin Haematol. 2006; 19(3):413-37.
Score: 0.009
-
Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2006; 199-204.
Score: 0.009
-
Myelodysplastic/myeloproliferative diseases. Cancer Treat Res. 2004; 121:13-43.
Score: 0.008
-
Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases. Semin Diagn Pathol. 2003 Aug; 20(3):154-79.
Score: 0.008
-
The new World Health Organization classification of myeloid neoplasms: Q&A with James W. Vardiman, MD. Clin Adv Hematol Oncol. 2003 Jan; 1(1):18, 21.
Score: 0.007
-
The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002 Oct 01; 100(7):2292-302.
Score: 0.007
-
Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary. Blood. 2002 Apr 15; 99(8):3074-5.
Score: 0.007
-
Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000; 11 Suppl 1:3-10.
Score: 0.006
-
The Conundrum of Diagnosing Cutaneous Composite Lymphoma in the Molecular Age. Am J Dermatopathol. 2019 Oct; 41(10):757-766.
Score: 0.006
-
Burkitt's lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Blood. 1999 Feb 01; 93(3):1124.
Score: 0.006
-
New entities, issues, and controversies in the classification of malignant lymphoma. Semin Oncol. 1998 Aug; 25(4):421-34.
Score: 0.005
-
Morphologic bone marrow changes in patients with posttransplantation lymphoproliferative disorders. Am J Surg Pathol. 1998 Feb; 22(2):208-14.
Score: 0.005
-
Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive. Leukemia. 1998 Feb; 12(2):233-7.
Score: 0.005
-
Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia. Leukemia. 1996 May; 10(5):795-802.
Score: 0.005
-
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 05 19; 127(20):2391-405.
Score: 0.005
-
Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. Semin Hematol. 1996 Apr; 33(2):111-26.
Score: 0.005
-
Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia. 1996 Jan; 10(1):20-6.
Score: 0.005
-
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice. Blood. 2016 Jan 21; 127(3):310-3.
Score: 0.005
-
Hematopathologic findings in the myeloproliferative disorders. Semin Oncol. 1995 Aug; 22(4):355-73.
Score: 0.004
-
The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia. 1995 Apr; 9(4):628-33.
Score: 0.004
-
Hodgkin's disease associated with chronic lymphocytic leukemia. Eight additional cases, including two of the nodular lymphocyte predominant type. Am J Clin Pathol. 1995 Apr; 103(4):479-84.
Score: 0.004
-
Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia. 1994 Sep; 8(9):1533-8.
Score: 0.004
-
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood. 1994 May 15; 83(10):2931-8.
Score: 0.004
-
PLZF staining identifies peripheral T-cell lymphomas derived from innate-like T-cells with TRAV1-2-TRAJ33 TCR-a rearrangement. Blood. 2014 Apr 24; 123(17):2742-3.
Score: 0.004
-
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica. 2014 May; 99(5):821-9.
Score: 0.004
-
Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am J Clin Pathol. 1993 Apr; 99(4):513-25.
Score: 0.004
-
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood. 1993 Mar 15; 81(6):1580-5.
Score: 0.004
-
Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802. Cancer. 2013 Jan 01; 119(1):90-8.
Score: 0.004
-
Issues in the pathology of the myelodysplastic syndromes. Hematol Oncol Clin North Am. 1992 Jun; 6(3):501-22.
Score: 0.004
-
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun. 2012 Feb 21; 3:688.
Score: 0.003
-
MPN-associated myelofibrosis (MPN-MF). Leuk Res. 2011 Jan; 35(1):12-3.
Score: 0.003
-
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808. Blood. 2010 Sep 02; 116(9):1413-21.
Score: 0.003
-
Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol. 1990 Apr; 14(4):305-16.
Score: 0.003
-
The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia. 1989 Dec; 3(12):866-70.
Score: 0.003
-
Bone marrow fibrosis and diagnosis of essential thrombocythemia. J Clin Oncol. 2009 Dec 01; 27(34):e220-1; author reply e222-3.
Score: 0.003
-
Pomalidomide is active in the treatment of anemia associated with myelofibrosis. J Clin Oncol. 2009 Sep 20; 27(27):4563-9.
Score: 0.003
-
The histopathologic diagnosis and subclassification of Hodgkin's disease. Hematol Oncol Clin North Am. 1989 Jun; 3(2):187-204.
Score: 0.003
-
Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations. Leukemia. 1989 Mar; 3(3):182-91.
Score: 0.003
-
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803). Cancer. 2009 Jan 01; 115(1):84-93.
Score: 0.003
-
Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. Blood. 1988 Oct; 72(4):1333-9.
Score: 0.003
-
Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Am J Clin Pathol. 1988 Sep; 90(3):250-6.
Score: 0.003
-
The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells. Leuk Lymphoma. 2008 Aug; 49(8):1567-77.
Score: 0.003
-
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008 Sep 01; 112(5):1646-54.
Score: 0.003
-
Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia. Leuk Res. 2008 Nov; 32(11):1770-5.
Score: 0.003
-
Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features. Clin Lab Med. 1988 Mar; 8(1):179-95.
Score: 0.003
-
Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood. 1987 Nov; 70(5):1412-7.
Score: 0.003
-
Nonlymphoblastic T-cell lymphoma in children. Cancer. 1987 Jun 15; 59(12):2099-103.
Score: 0.003
-
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood. 2007 Sep 01; 110(5):1648-55.
Score: 0.002
-
Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. Leukemia. 1987 Apr; 1(4):340-3.
Score: 0.002
-
Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol. 1987 Mar; 18(3):211-25.
Score: 0.002
-
Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leuk Res. 2007 Jun; 31(6):737-40.
Score: 0.002
-
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol. 2006 Aug 20; 24(24):3904-11.
Score: 0.002
-
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood. 2006 Sep 01; 108(5):1497-503.
Score: 0.002
-
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study. Blood. 2006 Sep 01; 108(5):1677-83.
Score: 0.002
-
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Blood. 2006 Jul 01; 108(1):63-73.
Score: 0.002
-
Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Am J Clin Pathol. 1986 Feb; 85(2):194-201.
Score: 0.002
-
Sequential treatment of hairy cell leukemia: a new role for interferon. Important Adv Oncol. 1986; 311-21.
Score: 0.002
-
Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist? Blood. 1985 Dec; 66(6):1358-61.
Score: 0.002
-
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. J Clin Oncol. 2005 Dec 20; 23(36):9234-42.
Score: 0.002
-
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol. 2005 Aug 20; 23(24):5705-17.
Score: 0.002
-
Autopsy findings in hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4):370-80.
Score: 0.002
-
Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4 Suppl 2):502-8.
Score: 0.002
-
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. J Clin Oncol. 2005 Jan 20; 23(3):482-93.
Score: 0.002
-
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621. J Clin Oncol. 2004 Nov 01; 22(21):4290-301.
Score: 0.002
-
Extramedullary hematopoiesis. Arch Dermatol. 1984 Oct; 120(10):1282.
Score: 0.002
-
Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Ann Hematol. 2004 Aug; 83(8):513-21.
Score: 0.002
-
A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol. 1984 Jun; 81(6):733-41.
Score: 0.002
-
Sinus histiocytosis with massive lymphadenopathy: response to cyclophosphamide therapy. Cancer Treat Rep. 1984 Jun; 68(6):901-2.
Score: 0.002
-
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Cancer. 2004 Apr 01; 100(7):1438-48.
Score: 0.002
-
Fourth International Workshop on Chromosomes in Leukemia 1982: Correlation between morphology and karyotype. Cancer Genet Cytogenet. 1984 Mar; 11(3):275-81.
Score: 0.002
-
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood. 2004 Jun 01; 103(11):4036-42.
Score: 0.002
-
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. Br J Haematol. 2004 Feb; 124(3):275-88.
Score: 0.002
-
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461. Ann Hematol. 2004; 83 Suppl 1:S84-5.
Score: 0.002
-
Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2004; 297-317.
Score: 0.002
-
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14275-80.
Score: 0.002
-
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Blood. 2003 Sep 01; 102(5):1613-8.
Score: 0.002
-
Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia. Am J Clin Pathol. 1983 May; 79(5):525-30.
Score: 0.002
-
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003 Jul 01; 102(1):43-52.
Score: 0.002
-
Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood. 1983 Feb; 61(2):349-52.
Score: 0.002
-
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. Leukemia. 2003 Feb; 17(2):323-7.
Score: 0.002
-
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Int J Oncol. 2002 Nov; 21(5):1041-51.
Score: 0.002
-
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood. 2003 Jan 01; 101(1):6-14.
Score: 0.002
-
Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia. Am J Hematol. 1982 Jun; 12(4):397-401.
Score: 0.002
-
Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1982 Apr; 5(4):281-92.
Score: 0.002
-
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res. 2001 Oct 01; 61(19):7233-9.
Score: 0.002
-
Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 1981 Oct; 58(4):759-67.
Score: 0.002
-
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001 Jul; 25(7):603-25.
Score: 0.002
-
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol. 2001 May 01; 19(9):2482-92.
Score: 0.002
-
Prognostic significance of immunological tests in lung cancer. Clin Exp Immunol. 1981 Feb; 43(2):362-9.
Score: 0.002
-
Karyotypic patterns and their clinical significance in polycythemia vera. Am J Hematol. 1981; 11(1):29-45.
Score: 0.002
-
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol. 2000 Feb; 13(2):193-207.
Score: 0.002
-
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology. 2000 Jan; 36(1):69-86.
Score: 0.002
-
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J. 2000; 1(1):53-66.
Score: 0.002
-
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999 Dec; 17(12):3835-49.
Score: 0.001
-
The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999 Dec; 10(12):1419-32.
Score: 0.001
-
Hairy cell leukemia: an autopsy study. Cancer. 1979 Apr; 43(4):1339-49.
Score: 0.001
-
Hairy cell leukemia: diagnosis and management. CA Cancer J Clin. 1978 Sep-Oct; 28(5):265-77.
Score: 0.001
-
Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study. Cancer. 1978 Jul; 42(1):229-42.
Score: 0.001
-
Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer. 1998 May; 22(1):72-8.
Score: 0.001
-
Acute leukemia after treatment of lymphoma. N Engl J Med. 1977 Nov 03; 297(18):1013.
Score: 0.001
-
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol. 1997 Nov; 99(2):344-51.
Score: 0.001
-
Myeloid leukemia after hematotoxins. Environ Health Perspect. 1996 Dec; 104 Suppl 6:1303-7.
Score: 0.001
-
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. Blood. 1996 May 15; 87(10):4076-81.
Score: 0.001
-
Malignant histiocytosis with massive splenomegaly in asymptomatic patients. A possible chronic form of the disease. Cancer. 1975 Aug; 36(2):419-27.
Score: 0.001
-
Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia. 1995 Jan; 9(1):95-101.
Score: 0.001
-
Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignancies. Leuk Lymphoma. 1994 Jul; 14(3-4):257-62.
Score: 0.001
-
T-cell-rich B-cell lymphoma of the spleen. Am J Surg Pathol. 1994 Mar; 18(3):323-4.
Score: 0.001
-
HTLV-I sequence in lymphoproliferative disorders. Diagn Mol Pathol. 1993 Sep; 2(3):192-9.
Score: 0.001
-
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood. 1993 Aug 01; 82(3):737-43.
Score: 0.001
-
Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia. Br J Haematol. 1993 Mar; 83(3):519-20.
Score: 0.001
-
Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood. 1992 Dec 01; 80(11):2873-82.
Score: 0.001
-
Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia. Blood. 1992 Nov 15; 80(10):2463-70.
Score: 0.001
-
Expression of the IFN alpha receptor in hairy cell leukaemia. Br J Haematol. 1992 Nov; 82(3):541-6.
Score: 0.001
-
Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood. 1992 Apr 01; 79(7):1796-801.
Score: 0.001
-
Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood. 1992 Mar 15; 79(6):1501-10.
Score: 0.001
-
The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure. Br J Haematol. 1991 Nov; 79(3):390-7.
Score: 0.001
-
Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: an analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia. Blood. 1991 Jun 01; 77(11):2456-62.
Score: 0.001
-
CD5+, CD11c+, CD20+ hairy cell leukemia. Blood. 1991 Apr 01; 77(7):1617-9.
Score: 0.001
-
Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia. Blood. 1991 Mar 15; 77(6):1397-8.
Score: 0.001
-
Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation. Blood. 1991 Mar 01; 77(5):1087-91.
Score: 0.001
-
t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 1990 Dec 15; 76(12):2594-8.
Score: 0.001
-
Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppression. Leukemia. 1990 Dec; 4(12):863-5.
Score: 0.001
-
Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood. 1990 Nov 15; 76(10):1941-5.
Score: 0.001
-
Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11). Genes Chromosomes Cancer. 1990 Jul; 2(2):147-58.
Score: 0.001
-
Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe. Am J Pathol. 1990 Jan; 136(1):131-9.
Score: 0.001
-
Low-dose interferon alfa-2b in the treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Aug 02; 81(15):1172-4.
Score: 0.001
-
Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer. 1988 Dec 01; 62(11):2420-4.
Score: 0.001
-
Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
Score: 0.001
-
A recurring chromosome rearrangement, dic(16;22), in acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1988 Oct 15; 35(2):143-50.
Score: 0.001
-
Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia. 1988 Feb; 2(2):79-83.
Score: 0.001
-
Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7.
Score: 0.001
-
Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood. 1986 Dec; 68(6):1242-9.
Score: 0.001
-
The role of interferon in the treatment of hairy cell leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):21-8.
Score: 0.001
-
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. J Clin Oncol. 1986 Jun; 4(6):900-5.
Score: 0.001
-
Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 1986 Jun; 67(6):1765-72.
Score: 0.001
-
Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May; 80(5):891-6.
Score: 0.001
-
Cat scratch disease. Identification of bacteria in seven cases of lymphadenitis. Am J Surg Pathol. 1986 Apr; 10(4):276-81.
Score: 0.001
-
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar; 4(3):325-45.
Score: 0.001
-
A 14;19 translocation in B-cell chronic lymphocytic leukemia: a new recurring chromosome aberration. Int J Cancer. 1985 Sep 15; 36(3):287-90.
Score: 0.001
-
Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment. Br J Haematol. 1985 Jul; 60(3):457-67.
Score: 0.001
-
Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL. Am J Hematol. 1985 Apr; 18(4):393-403.
Score: 0.001
-
Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 1985 Mar; 65(3):644-8.
Score: 0.001
-
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med. 1984 May; 76(5):827-41.
Score: 0.001
-
Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma. N Engl J Med. 1984 Jan 26; 310(4):263-4.
Score: 0.000
-
The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genet Cytogenet. 1983 Nov; 10(3):219-36.
Score: 0.000
-
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med. 1983 Sep 15; 309(11):630-6.
Score: 0.000
-
Development of dysmyelopoietic syndrome in a hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation. Cancer Genet Cytogenet. 1983 Feb; 8(2):107-15.
Score: 0.000
-
Histiocytic lymphoma: response to chemotherapy. Ann Intern Med. 1982 Oct; 97(4):617-8.
Score: 0.000
-
Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982 Aug; 60(2):404-11.
Score: 0.000
-
Ultrastructural characterization of de novo and secondary leukemias. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 39(3):239-57.
Score: 0.000
-
Multiple histologic subtypes of non-Hodgkin's lymphoma: clinical and pathologic features. Cancer. 1981 Nov 01; 48(9):2063-9.
Score: 0.000
-
Hairy cell leukemia in father and son. Cancer. 1981 Oct 15; 48(8):1825-9.
Score: 0.000
-
Human T-cell lymphoma with suppressor effects on the mixed lymphocyte reaction (MLR). I. Morphological and cytogenetic analysis. Blood. 1981 Apr; 57(4):634-41.
Score: 0.000
-
Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia. Cancer. 1980 Jul 01; 46(1):50-5.
Score: 0.000
-
Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies. Blood. 1980 Apr; 55(4):636-44.
Score: 0.000
-
"Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity. Blood. 1980 Feb; 55(2):253-9.
Score: 0.000
-
Cytochemistry of hairy cells. Cancer. 1980 Jan 01; 45(1):72-7.
Score: 0.000
-
Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res. 1979 Sep; 39(9):3619-27.
Score: 0.000
-
Neutrophilic leucocyte alkaline phosphatase scores in hairy cell leukaemia: cytochemical, functional, and clinical correlations. Br J Haematol. 1979 Sep; 43(1):156-7.
Score: 0.000
-
Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia. Cancer. 1979 Feb; 43(2):411-6.
Score: 0.000
-
Differential counts and survival in lung cancer. Lancet. 1978 Dec 16; 2(8103):1317-8.
Score: 0.000
-
Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). N Engl J Med. 1978 Sep 21; 299(12):613-9.
Score: 0.000
-
Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity. Blood. 1978 Aug; 52(2):272-80.
Score: 0.000
-
Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics. Br J Haematol. 1978 Feb; 38(2):161-70.
Score: 0.000
-
Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia. Int J Cancer. 1977 Dec 15; 20(6):869-72.
Score: 0.000
-
Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations. Blood. 1977 Jun; 49(6):883-93.
Score: 0.000
-
Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. Blood. 1976 Jul; 48(1):9-21.
Score: 0.000
-
Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia? Arch Intern Med. 1976 Jul; 136(7):825-8.
Score: 0.000
-
Mesocolic lymph node histology is an important prognostic indicator for patients with carcinoma of the sigmoid colon: an immunomorphologic study. Cancer. 1975 May; 35(5):1388-96.
Score: 0.000